SIGLEC1 and hepatocellular carcinoma: In addition, the ratios of CD204+/CD169+ Mφs were significantly increased in IT as compared with NT regions of HCC but not in GC (1.2 ± 0.05 and 14.1 ± 1.9 in the NT and IT, respectively; P < 0.01; Fig. 1e).